Literature DB >> 9236426

Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. An observational study.

P B Berger1, D R Holmes, A L Stebbins, E R Bates, R M Califf, E J Topol.   

Abstract

BACKGROUND: Although retrospective analyses have revealed an association between survival and coronary angiography and angioplasty in patients with acute myocardial infarction complicated by cardiogenic shock, the degree to which bias in the selection of patients to undergo these procedures contributes to this observation remains unclear. METHODS AND
RESULTS: We studied 2200 patients in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial with acute myocardial infarction complicated by cardiogenic shock (systolic blood pressure < 90 mm Hg for > or = 1 hour) who survived > or = 1 hour after the onset of shock to determine the influence of an aggressive strategy of early angiography (within 24 hours of shock onset) and coronary angioplasty or bypass surgery, if appropriate, on survival. Revascularization was not protocol mandated but was selected by the attending physicians. Shock was present on admission in 11% and developed after admission in 89% of shock patients. The 30-day mortality was 38% in the 406 patients who underwent early angiography and were referred within 24 hours for angioplasty (n = 175), bypass surgery (n = 36), angioplasty and bypass surgery (n = 22), or neither (late or no revascularization, n = 173) compared with 62% in the 1794 patients who did not (P = .0001). However, there were important differences in the baseline characteristics of the two groups, including younger age (63 versus 68 years, P = .0001), less prior infarction (19% versus 27%, P = .001), and a shorter time to thrombolytic therapy (2.9 versus 3.2 hours, P = .0001) in patients treated with an aggressive strategy. Using multivariate logistic regression analysis to adjust for differences in baseline characteristics, an aggressive strategy was independently associated with reduced 30-day mortality (odds ratio, 0.43 [confidence interval, 0.34 to 0.54], P = .0001).
CONCLUSIONS: An aggressive strategy of early angiography (and revascularization when appropriate) is associated with a reduction in mortality in patients with acute myocardial infarction and cardiogenic shock who receive thrombolytic therapy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9236426     DOI: 10.1161/01.cir.96.1.122

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  21 in total

Review 1.  Management of cardiogenic shock complicating acute myocardial infarction: towards evidence based medical practice.

Authors:  S G Williams; D J Wright; L B Tan
Journal:  Heart       Date:  2000-06       Impact factor: 5.994

Review 2.  Management of cardiogenic shock complicating acute myocardial infarction.

Authors:  Venu Menon; Judith S Hochman
Journal:  Heart       Date:  2002-11       Impact factor: 5.994

Review 3.  ABC of interventional cardiology. Percutaneous coronary intervention: cardiogenic shock.

Authors:  John Ducas; Ever D Grech
Journal:  BMJ       Date:  2003-06-28

4.  Predictors of outcome after percutaneous treatment for cardiogenic shock.

Authors:  A G C Sutton; P Finn; J A Hall; A A Harcombe; R A Wright; M A de Belder
Journal:  Heart       Date:  2005-03       Impact factor: 5.994

Review 5.  Immediate angioplasty after thrombolysis: a systematic review.

Authors:  Warren J Cantor; Fabrice Brunet; Carolyn P Ziegler; Alex Kiss; Laurie J Morrison
Journal:  CMAJ       Date:  2005-12-06       Impact factor: 8.262

Review 6.  [Reperfusion therapy and mechanical circulatory support in patients in cardiogenic shock].

Authors:  K H Scholz
Journal:  Herz       Date:  1999-10       Impact factor: 1.443

Review 7.  [Therapy of acute myocardial infarct--primary PTCA or thrombolysis?].

Authors:  A Vogt; K L Neuhaus
Journal:  Herz       Date:  1999-08       Impact factor: 1.443

8.  Acute myocardial infarction with cardiogenic shock on admission: incidence, prognostic implications, and current treatment strategies. Results from "the 60-Minutes Myocardial Infarction Project". ALKK ("Arbeitsgemeinschaft leitender Krankenhauskardiologen") Study Group.

Authors:  W Beermann; J Carlsson; J Rustige; R Schiele; J Senges; U Tebbe
Journal:  Herz       Date:  1999-08       Impact factor: 1.443

9.  Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective.

Authors:  Robert J Goldberg; Frederick A Spencer; Joel M Gore; Darleen Lessard; Jorge Yarzebski
Journal:  Circulation       Date:  2009-02-23       Impact factor: 29.690

10.  Unprotected left main coronary artery intervention for acute myocardial infarction and cardiogenic shock.

Authors:  Mohammed M Abuzahra; Andres Mesa; Bernardo Treistman
Journal:  Tex Heart Inst J       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.